Home » Authors » Omar Ford

Omar Ford

Articles

ARTICLES

Simulation: unproven, costly but beginning to gain traction

Oct. 25, 2007

ExThera formed to treat sepsis as latest device/drug matchup

Oct. 22, 2007

Virtual Companies Project used to boost Michigan's economy

Oct. 16, 2007

In $42M buy, QLT has ForSight to address glaucoma patients

Oct. 10, 2007

Apollo in ‘A’ $11.5 million round; Simplex Diabetic garners $50M

Oct. 9, 2007

Panelist: ‘Focus’ essential for medical device start ups

Oct. 8, 2007

Med-tech landscape is sunny, but watch out for ‘storm clouds’

Oct. 5, 2007

Spectranetics launches PATENT trial for SFA instent restenosis

Oct. 3, 2007

Calcification attack, but adjacent tissue safety via Diamondback

Oct. 1, 2007

Product briefs: Digital Health wins PMA for Retasure retinopathy detection

Oct. 1, 2007

View All Articles by Omar Ford

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...